Avanos appoints Jason Pickett as Interim CFO; Greiner departs with $2.1M severance

AVANOS MEDICAL, INC.

Michael Greiner departs after not being offered comparable role post-interim CEO; receives $2.1M severance, prorated bonus, $50K consulting fee.
Jason Pickett named Interim CFO and Treasurer effective April 14; salary $350K/year plus $30K/month stipend.
Pickett granted special $200K TRSU award with 12-month vesting on April 22.
Warren Machan transitions from Interim CFO to consultant through April 30 at $60K/month; no second bonus.
Greiner's 54,189 special TRSUs vest immediately; all other unvested equity forfeited.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Warren J. Machan

Interim Chief Financial Officer

AVNS · AVANOS MEDICAL, INC.

Effective: 2025-04-14
Successor: Jason M. Pickett
Filed: April 28, 2025, 7:59 PM ET

Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025

Departed

Michael C. Greiner

Senior Vice President, Chief Financial Officer and Chief Transformation Officer

AVNS · AVANOS MEDICAL, INC.

Effective: 2025-04-18
Filed: April 28, 2025, 7:59 PM ET

On April 18, 2025, Michael C. Greiner announced that he will leave the Company to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.

Appointed (interim)

Jason M. Pickett

Interim Chief Financial Officer and Treasurer

AVNS · AVANOS MEDICAL, INC.

Effective: 2025-04-14
Filed: April 28, 2025, 7:59 PM ET

The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Warren J. Machan departed as Interim Chief Financial Officer at AVANOS MEDICAL, INC..

Action: no longer serves
Role: Interim Chief Financial Officer

Exact text from the filing

Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael C. Greiner departed as Senior Vice President, Chief Financial Officer and Chief Transformation Officer at AVANOS MEDICAL, INC..

Action: announced that he will leave
Role: Senior Vice President, Chief Financial Officer and Chief Transformation Officer

Exact text from the filing

On April 18, 2025, Michael C. Greiner announced that he will leave the Company to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason M. Pickett was appointed as Interim Chief Financial Officer and Treasurer at AVANOS MEDICAL, INC..

Action: appointed
Role: Interim Chief Financial Officer and Treasurer

Exact text from the filing

The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.

View on SEC.gov

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-25-000081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.